CD8 + T cells induce RIPK1-regulated brain endothelial cell death in cerebral malaria
Authors:
- Alexandros HadjilaouAHAlexandros Hadjilaou
- Johannes BrandiJBJohannes Brandi
- Jan Broder EnglerJEJan Broder Engler
- Ana MatcharashviliAMAna Matcharashvili
- Tatiana GoncharovTGTatiana Goncharov
- Carla JohnsonCJCarla Johnson
- Nikita VladimirovNVNikita Vladimirov
- Charlotte SchubertCSCharlotte Schubert
- Praveen K. SahuPSPraveen K. Sahu
- Linda DrewickeLDLinda Drewicke
Open Access
- 6 November 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
Abstract
Cerebral malaria (CM) is a potentially lethal complication of Plasmodium falciparum infection characterized by blood-brain barrier disruption and brain hemorrhage. Although immune-mediated endothelial damage is central to CM pathology, the mechanisms linking cytotoxic immune responses to endothelial injury remain unclear. Here, we show that CD8 + T cells induce receptor-interacting serine/threonine-protein kinase 1 (RIPK1)–regulated cell death of brain endothelial cells in mouse CM, while RIPK1 phosphorylation is increased in brain endothelial cells in human CM. Using magnetic resonance imaging, three-dimensional tissue-cleared brain imaging, cross-species pathology, endothelial translatomics, immunocerebrovascular interactomics, and genetic association testing, we identify a CD8 + T cell–dependent, RIPK1-centered mouse endothelial cell death program. Combined RIPK1 and caspase inhibition protected cross-presenting endothelial cells from CD8 + T cell–mediated death in vitro. In vivo, brain endothelial-specific genetic inactivation or systemic pharmacological inhibition of RIPK1 kinase activity prolonged survival in mouse CM without altering parasitemia. These findings support RIPK1 inhibition as a promising therapeutic strategy to counter CD8 + T cell–induced endothelial death in CM.Keywords
Funding Information
- National Institutes of Health (U19AI089676)
- National Institutes of Health (U19AI181587)
- Deutsches Zentrum für Infektionsforschung (TI 07.001_002)
- Deutsches Zentrum für Infektionsforschung (TI 07.002)
- Medical Research Council (UKRI1505)
- Deutsche Forschungsgemeinschaft (SFB 1648/1 (2024) 512741711)
- Else Kröner-Fresenius-Stiftung (2021_EKPK.10)
- Werner Otto Stiftung (7/102)
- Research Foundation Flanders (3G0A9322, 3G0AA824)
- Foundation Against Cancer (365A08921, 365G09122)
- EOS research consortium (3G0I5722)
- UGent Special Research Fund Methusalem (01M00709)
- University Medical Center Hamburg-Eppendorf
This publication has 89 references indexed in Scilit:
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock SyndromesCell, 2021
- Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled StudyClinical Pharmacology & Therapeutics, 2020
- Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteersPharmacology Research & Perspectives, 2017
- Necroptosis-independent signaling by the RIP kinases in inflammationCellular and Molecular Life Sciences, 2016
- A Tie2‐driven BAC‐TRAP transgenic line for in vivo endothelial gene profilingGenesis, 2016
- Whole-Brain Imaging with Single-Cell Resolution Using Chemical Cocktails and Computational AnalysisCell, 2014
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Brain microvessel cross‐presentation is a hallmark of experimental cerebral malariaEMBO Molecular Medicine, 2013
- The Neuropathology of Fatal Cerebral Malaria in Malawian ChildrenThe American Journal of Pathology, 2011
- Exact prediction of a natural T cell epitopeEuropean Journal of Immunology, 1991